News and Press Releases

Martyn Coombs

Martyn Coombs to Advise SHINE

March 27, 2017 – Janesville, WI – SHINE Medical Technologies, Inc. (SHINE), a company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, announced today that Martyn Coombs will become a Strategic Adviser to SHINE, on a part-time basis. The announcement comes as the company prepares to build its facility in Janesville, Wisconsin, after receiving its construction permit from the U.S. Nuclear Regulatory Commission last year.

Gregory Smith

Gregory OD Smith Joins SHINE’s Board of Directors

February 13th, 2017 – Janesville, WI – SHINE Medical Technologies, Inc. (SHINE), a company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, announced today that Gregory Smith will join its Board of Directors. The appointment comes as the company prepares to build its facility in Janesville, Wisconsin, after receiving its construction permit from the U.S. Nuclear Regulatory Commission last year. The SHINE facility will produce molybdenum-99 (moly‑99) and other medical isotopes.

SHINE Ribbon Cutting Event

Ribbon Cutting Ceremony Held to Celebrate Grand Opening of SHINE new Global Headquarters

January 16, 2017 – SHINE Medical Technologies, Inc. (SHINE), a company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, held a ribbon cutting ceremony to celebrate the grand opening of the company’s new global headquarters in downtown Janesville, Wisconsin. The ribbon cutting was led by the John Beckord and the Forward Janesville Goodwill Ambassadors.

Piper Jaffray Logo

SHINE Medical Technologies to Present at Piper Jaffray Healthcare Conference

November 17, 2016 – SHINE Medical Technologies, Inc. (SHINE), a Wisconsin-based company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, announced today that the company has been invited to speak at the 28th Annual Piper Jaffray Healthcare Conference in New York.

coj-tree-logo

SHINE Medical Technologies to Move Headquarters to Janesville, Wisconsin

September 23, 2016 – SHINE Medical Technologies, Inc. (SHINE), a Wisconsin-based company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, announced plans to move its headquarters from Monona to downtown Janesville, Wisconsin late this year.

Katrina headsshot

SHINE Medical Technologies Invited to Present at 2016 DOE/NNSA Mo-99 Topical Meeting

September 6, 2016 – SHINE Medical Technologies, Inc. (SHINE), a Wisconsin-based company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, announced today that the company has been invited to speak at the 2016 Mo-99 Topical Meeting hosted by the Department of Energy’s National Nuclear Security Administration (DOE/NNSA).

HTA Co., Ltd.

HTA and SHINE Announce Moly-99 Supply Agreement

June 21, 2016 – HTA Co., Ltd. (HTA), the largest Chinese producer and distributor of radio-pharmaceuticals, and SHINE Medical Technologies (SHINE), a U.S. company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, announced today that the companies have entered into a strategic agreement for the supply of molybdenum-99 (moly-99).

Nuclear Regulatory Commission Logo

SHINE Medical Receives Regulatory Approval: Nuclear Regulatory Commission to Issue Construction Permit

February 25, 2016 – SHINE Medical Technologies, Inc., a Wisconsin-based company dedicated to being the world leader in the safe, clean, affordable production of medical tracers and cancer treatment elements, announced today that the U.S. Nuclear Regulatory Commission (NRC) has authorized issuance of the SHINE construction permit.

Shine Medical Technologies Logo

SHINE holds 2nd 2015 Community Meeting

December 7, 2015 – SHINE invites the Janesville community to an update on the development of its medical isotope production facility. Since our last meeting in June, SHINE’s primary regulator, the Nuclear Regulatory Commission, has completed their safety and environmental reviews and recommended the approval of a Construction Permit for the SHINE facility.

Shine Medical Technologies Logo

SHINE Achieves Major Milestone on Path to Construction Permit Approval

October 26, 2015 – SHINE Medical Technologies, Inc., a Wisconsin-based company dedicated to being the world leader in the safe, clean, affordable production of medical tracers and cancer treatment elements, announced today that the staff of its primary regulator, the Nuclear Regulatory Commission (NRC), has completed their safety and environmental reviews and recommends approval of a Construction Permit for the SHINE facility.

pr_180-99mo

Additional $2 Million DOE/NNSA Award Accelerates SHINE Production of Medical Isotopes

October 25, 2015 – SHINE Medical Technologies, Inc. (SHINE), a Wisconsin-based medical isotope company, announced today that it has been awarded $1 million from the U.S. Department of Energy’s National Nuclear Security Administration (DOE/NNSA) as part of a $2 million cooperative agreement.

srnlimage

SHINE Signs License Agreement for SRNL Innovation

October 14, 2015 – Savannah River Nuclear Solutions, LLC (SRNS), the management and operating contractor for the U.S. Department of Energy’s Savannah River National Laboratory (SRNL), has granted SHINE Medical Technologies, Inc. (SHINE) an exclusive license on SRNL’s patented hydrogen isotope separation process for use in medical isotope production.

gregaccelerator

UW-Madison spinoff on track to build isotope source in Janesville

October 6, 2015 – SHINE Medical Technologies of Madison is moving ahead with an effort to make a vital medical isotope at a new plant in Janesville. The isotope, molybdenum-99, is needed for about 20 million procedures annually in the United States alone. “Moly-99” quickly decays into a form, technetium-99, that is useful for medical scans used to detect cancer and assess blood supply to the heart.

toddbiopic

Todd Asmuth Joins SHINE Medical Technologies Team

October 1, 2015 – SHINE Medical Technologies, Inc. (SHINE), a Wisconsin-based company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, announced today that Todd Asmuth will join the company as President, reporting to the CEO and focusing on investor and customer relations. The appointment comes as the company prepares to bring its first product to market, molybdenum-99 (moly-99).

jeffdphoto

NSF Award Helps SHINE Accelerate Efforts to Become a Major Domestic Producer of Iodine-131

June 30, 2015 – SHINE Medical Technologies, a Wisconsin-based medical isotope company, announced today that it has been awarded $150,000 from the National Science Foundation for Phase I of an SBIR (Small Business Innovation Research) Grant. This grant will fast-track SHINE’s ongoing development of iodine-131 extraction and purification processes, which SHINE may decide to pursue at its medical isotope production facility.